WELLS FARGO & COMPANY/MN - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 146 filers reported holding VIKING THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,393,459
-14.4%
125,877
+25.4%
0.00%
Q2 2023$1,627,127
+7.5%
100,378
+10.4%
0.00%
Q1 2023$1,513,402
+10604.5%
90,895
+5943.6%
0.00%
Q4 2022$14,138
+371.3%
1,504
+25.5%
0.00%
Q3 2022$3,000
-66.7%
1,198
-62.7%
0.00%
Q2 2022$9,000
-94.8%
3,211
-94.4%
0.00%
Q1 2022$174,000
-53.0%
57,842
-28.2%
0.00%
Q4 2021$370,000
-48.3%
80,508
-29.3%
0.00%
Q3 2021$716,000
-6.3%
113,841
-10.6%
0.00%
Q2 2021$764,000
-36.9%
127,394
-33.5%
0.00%
Q1 2021$1,211,000
-27.5%
191,533
-35.4%
0.00%
Q4 2020$1,670,000
+16.5%
296,462
+20.4%
0.00%
Q3 2020$1,433,000
-22.4%
246,275
-3.9%
0.00%
-100.0%
Q2 2020$1,847,000
+73.9%
256,140
+12.9%
0.00%
Q1 2020$1,062,000
-43.8%
226,905
-3.6%
0.00%
-100.0%
Q4 2019$1,888,000
+7.5%
235,262
-7.9%
0.00%
Q3 2019$1,756,000
-14.0%
255,381
+3.9%
0.00%
-100.0%
Q2 2019$2,041,000
-34.4%
245,751
-21.5%
0.00%0.0%
Q1 2019$3,113,000
+39.4%
313,101
+7.3%
0.00%0.0%
Q4 2018$2,233,000
+94.9%
291,864
+343.5%
0.00%
Q3 2018$1,146,000
+105.4%
65,810
+12.0%
0.00%
Q2 2018$558,000
+6100.0%
58,773
+840.4%
0.00%
Q3 2016$9,000
+12.5%
6,2500.0%0.00%
Q2 2016$8,000
-11.1%
6,2500.0%0.00%
Q1 2016$9,000
-57.1%
6,2500.0%0.00%
Q4 2015$21,0006,2500.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders